NextGen Sciences Announces Commercial Alliance with Paragon Bioservices
News Jan 07, 2008
The Alliance expands the portfolio of both companies with the ability to offer existing and future customers an integrated offering including molecular biology, protein production, proteomics, functional assay development, biomarker discovery and monitoring.
NextGen Sciences says that this alliance extends its commitment to expand their fee for service offering in strategic partnerships in addition to adding new capabilities in house such as the protein biomarker monitoring services which was announced in November 2007.
NextGen Sciences and Paragon Bioservices have agreed to co-market each others fee for service offerings to the market which now allows client companies to choose a one stop shop for their entire gene to protein needs.
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018